05/10/2011

Units of Cytology, Immunophenotype and cytogenetics of Hematology from Hospital Vall d'Hebron organized on October 5 the fourth Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases.The workshop third edition, led by Dr Teresa Vallespí, hematologist of Vall d'Hebron Research Institute (VHIR), was opened to 11 researchers coming from several centers of Spain. After an upgrade of the techniques used in integrated diagnostics, participants in groups of 2 or 3, developed problems supervised by experts from different units.During the conference, sponsored by Celgene, the participants studied, together with the respective experts, the different aspects of the malignant clone. For pupils it means making contact with the most advanced scanners that are used in the diagnostic study (karyotyping, flow cytometry 10 colors). After the process, they made the diagnosis by integrating all the data, implying a clear exercise of the specialty of Hematology. Furthermore, it confirmed the certainty that a correct diagnosis allows appropriate treatment and, at times, elements for further study of minimal residual disease (MRD).At the end of the day, workshop participants finished the experience with several objectives accomplished: delve into the key features in the diagnosis of MDS, analyze karyotypes with abnormalities most frequently observed in MDS, studying pictures with alterations in the expression of antigens or aberrant antigens and join all the previous clinical data, develop integrated diagnosis and classify the proposals according to FAB, IPSS (1997) and WHO (2008).The workshop, with class material, will have another edition on February due to the success of the last experiences and the wide demand.